Masonic Cancer Center, University of Minnesota

First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma

Role: lead

GTB-5550 in Advanced Solid Tumors

Role: lead

MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases

Role: lead

Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Role: lead

Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids

Role: lead

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

Role: lead

Observational Study of Exposure to Environmental Toxicants Among Firefighters

Role: lead

Allo HSCT for High Risk Hemoglobinopathies

Role: lead

Rural Smoking Cessation

Role: lead

Trial of Cell Based Therapy for DMD

Role: lead

Sugars in Cigarettes

Role: lead

A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering

Role: collaborator

Effect of Kava on Anxiety and Stress in Cancer Survivors

Role: lead

Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures

Role: lead

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Role: lead

Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies

Role: lead

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

Role: lead

Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users

Role: lead

MT2017-45: CAR-T Cell Therapy for Heme Malignancies

Role: lead

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies

Role: lead